Medical Arts Health Research Group

Kamloops, British Columbia V2C 1K7

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer's Disease, Hyperlipidemia

Studies at this site

• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed
• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed